» Articles » PMID: 14159445

IATROGENIC ENDOMETRIAL PATTERNS

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1964 May 1
PMID 14159445
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The histological patterns exhibited in the endometrium due to the newer progestational agents cannot be correlated with the patient's menstrual cycle or the physiological endometrium which follows ovulation. The oral progestational agents which have been produced during the past few years have had wide clinical application. Although the 19-nor-steroids and the derivatives of 17 alphahydroxyprogesterone differ in chemical structure, they produce similar histological appearances in the endometrium. Prolonged use of these compounds produces atrophy of the endometrial glands and a cellular stroma which might be mistaken for endometrial sarcoma. In view of the fact that such compounds are widely used in clinical practice and as contraceptive agents, it is essential that the pathologist should be aware of the bizarre endometrial patterns which they may produce; the more important of these changes are illustrated and discussed.

Citing Articles

Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.

Bokhari A, Baker T, Dorjbal B, Waheed S, Zahn C, Hamilton C Oncotarget. 2016; 7(43):69733-69748.

PMID: 27626172 PMC: 5342511. DOI: 10.18632/oncotarget.11947.


Progesterone action in breast, uterine, and ovarian cancers.

Diep C, Daniel A, Mauro L, Knutson T, Lange C J Mol Endocrinol. 2015; 54(2):R31-53.

PMID: 25587053 PMC: 4336822. DOI: 10.1530/JME-14-0252.


Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.

Janzen D, Rosales M, Paik D, Lee D, Smith D, Witte O Cancer Res. 2013; 73(15):4697-710.

PMID: 23744837 PMC: 3752407. DOI: 10.1158/0008-5472.CAN-13-0930.


Iatrogenic Endometrial Patterns.

Can Med Assoc J. 2010; 91(13):720.

PMID: 20327956 PMC: 1927643.


Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.

Zook B, SPIRO I, Hertz R Am J Pathol. 1987; 128(2):315-27.

PMID: 3039851 PMC: 1899614.

References
1.
PAULSEN C, Leach R, LANMAN J, GOLDSTON N, MADDOCK W, HELLER C . Inherent estrogenicity of norethindrone and norethynodrel: comparison with other synthetic progestins and progesterone. J Clin Endocrinol Metab. 1962; 22:1033-9. DOI: 10.1210/jcem-22-10-1033. View

2.
DOCKERTY M, Smith R, SYMMONDS R . Pseudomalignant endometrial changes induced by administration of new synthetic progestins. Proc Staff Meet Mayo Clin. 1959; 34:321-8. View

3.
Brown J, BLAIR H . Urinary Œstrogen Metabolites of 19-Norethisterone and its Esters [Summary]. Proc R Soc Med. 2009; 53(6):433. PMC: 1869986. View